Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

摘要

Kallistatin (KAL) inhibited the proliferation of ovarian cancer cells in vitro and in vivo. ( ) The effect of kallistatin on ovarian cancer cell proliferation as measured by MTT assays; A2780 and UWB1.289 cells were transfected stably with PCMV-NC and PCMV-KAL. A2780 and OVCAR3 cells were transfected transiently with kallistatin siRNA. ( ) Colony formation assays were used to measure the effect of kallistatin on A2780, UWB1.289 and OVCAR3 cell growth. ( ) Cell cycle analysis of A2780 and OVCAR3 cells. ( ) UWB1.289 cells stably transfected with PCMV-NC and PCMV-KAL were injected subcutaneously into nude female mice. The tumour weights in the PCMV-KAL group were significantly decreased compared with those in the control group. *  p p